
Welltower Inc. (WELL) stock recently reached an all-time high of $171.11, marking a 34.01% increase over the past year and reflecting robust market confidence in the healthcare REIT, which holds a $114.37 billion market capitalization and a 'GREAT' financial health score. The company reported strong Q2 2025 results, exceeding revenue projections by 4.08% to $2.55 billion and meeting EPS expectations. This positive momentum is reinforced by recent analyst upgrades, with KeyBanc raising its price target to $200 and UBS initiating coverage with a Buy rating and a $195 target, both citing anticipated Adjusted Funds From Operations (AFFO) growth and Welltower's strong position in the senior housing sector.
Welltower Inc. (WELL) has demonstrated significant market strength, achieving an all-time stock price high of $171.11, which reflects a year-over-year gain of 34.01%. This performance is underpinned by robust fundamentals, including a strong Q2 2025 financial report where the company met EPS expectations of $0.45 and exceeded revenue forecasts by 4.08%, posting $2.55 billion against an anticipated $2.45 billion. The market's confidence is further reinforced by bullish analyst sentiment; KeyBanc raised its price target to $200, and UBS initiated coverage with a Buy rating and a $195 target, with both firms citing Welltower's dominant position in the senior housing market and anticipated growth in Adjusted Funds From Operations (AFFO). While the company's 50-year history of dividend payments highlights its financial stability, the current valuation is noted as being above InvestingPro's Fair Value estimate, suggesting the stock is trading at a premium. The recent registration for the resale of shares is a technical filing related to a past property acquisition and does not represent new shareholder dilution.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment